Motesanib Terminated Phase 3 Trials for Non-Small Cell Lung Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00460317MONET1-MOtesanib NSCLC Efficacy and Tolerability Study